BAX Stock Recent News

BAX LATEST HEADLINES

BAX Stock News Image - Zacks Investment Research

Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.

Zacks Investment Research 2024 May 14
BAX Stock News Image - InvestorPlace

“Do one thing and do it well.” Over time, companies forget that sage advice, preferring instead to build mini empires.

InvestorPlace 2024 May 03
BAX Stock News Image - Zacks Investment Research

Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research 2024 May 02
BAX Stock News Image - Zacks Investment Research

Baxter International (BAX) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.59 per share a year ago.

Zacks Investment Research 2024 May 02
BAX Stock News Image - Zacks Investment Research

Besides Wall Street's top -and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.

Zacks Investment Research 2024 Apr 29
BAX Stock News Image - InvestorPlace

It's been a month since Boeing (NYSE: BA ) CEO Dave Calhoun announced that he would step down at the end of 2024. While his departure wasn't termed a “firing,” there is no question Calhoun's name would have been on a list, if there were one, of CEOs that need to be fired.

InvestorPlace 2024 Apr 23
BAX Stock News Image - Zacks Investment Research

Baxter (BAX) unveils its five injectable products, which strengthen its emphasis on unique products and expand the pharmaceutical portfolio of the business in important therapeutic areas.

Zacks Investment Research 2024 Apr 12
BAX Stock News Image - Zacks Investment Research

Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.

Zacks Investment Research 2024 Apr 11
BAX Stock News Image - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. Th.

Business Wire 2024 Apr 10
BAX Stock News Image - Zacks Investment Research

Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, raises optimism.

Zacks Investment Research 2024 Apr 10
10 of 50